Centre Asset Management’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-70,077
Closed -$7.61M 72
2024
Q2
$7.61M Sell
70,077
-9,604
-12% -$1.13M 1.75% 30
2024
Q1
$10.5M Sell
79,681
-4,072
-5% -$509K 2.51% 15
2023
Q4
$10.2M Sell
83,753
-4,330
-5% -$483K 2.46% 10
2023
Q3
$9.88M Buy
88,083
+6,661
+8% +$846K 2.41% 13
2023
Q2
$11.9M Buy
81,422
+7,161
+10% +$973K 2.62% 9
2023
Q1
$9.6M Buy
74,261
+1,176
+2% +$148K 2.32% 8
2022
Q4
$9.32M Buy
+73,085
New +$8.48M 2.47% 9
2013
Q3
Sell
-77,466
Closed -$5.64M 106
2013
Q2
$5.64M Buy
+77,466
New +$5.79M 0.92% 37

Other funds holding ZBH

Centre Asset Management's ZBH Position: Q3 2024 in Review

Centre Asset Management sold out of Zimmer Biomet (ZBH) in Q3 2024, closing a stake of 70,077 shares — an estimated $7.61M sold.

Centre Asset Management first reported a position in ZBH in Q2 2013 and held it in 8 quarters. The position peaked at $11.9M in Q2 2023. 981 funds tracked by Wall St. Rank hold ZBH as of Q3 2024.

  • Centre Asset Management reported no remaining Zimmer Biomet position as of Q3 2024 after selling out during the quarter.
  • Centre Asset Management sold 70,077 Zimmer Biomet shares in Q3 2024, an estimated $7.61M.
  • Centre Asset Management first reported a position in Zimmer Biomet in Q2 2013 and held it in 8 quarters.
  • Centre Asset Management's Zimmer Biomet position peaked at $11.9M in Q2 2023.
  • 981 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2024.

Based on Centre Asset Management's 13F filing for Q3 2024, filed 15 Oct 2024.